CYP2C19 Genetic Testing After PCI: A Promising Tool That Still Raises Practical Questions
Episode Summary
CYP2C19 genotyping may personalize antiplatelet therapy after PCI, identifying patients at risk for reduced clopidogrel response while supporting more targeted treatment decisions.